These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 11815499)
21. Increased risk of severe acute pancreatitis in patients with diabetes. Shen HN; Chang YH; Chen HF; Lu CL; Li CY Diabet Med; 2012 Nov; 29(11):1419-24. PubMed ID: 22506974 [TBL] [Abstract][Full Text] [Related]
22. Finasteride use and acute pancreatitis in Taiwan. Lai SW; Lai HC; Lin CL; Liao KF J Clin Pharmacol; 2015 Jun; 55(6):657-60. PubMed ID: 25573785 [TBL] [Abstract][Full Text] [Related]
23. Use of celecoxib correlates with increased relative risk of acute pancreatitis: a case-control study in Taiwan. Hung SC; Hung SR; Lin CL; Lai SW; Hung HC Am J Gastroenterol; 2015 Oct; 110(10):1490-6. PubMed ID: 26323189 [TBL] [Abstract][Full Text] [Related]
24. Increased risk of acute pancreatitis among tetracycline users in a Swedish population-based case-control study. Ljung R; Lagergren J; Bexelius TS; Mattsson F; Lindblad M Gut; 2012 Jun; 61(6):873-6. PubMed ID: 21957155 [TBL] [Abstract][Full Text] [Related]
25. Risk of hospitalization for acute pancreatitis associated with conventional and atypical antipsychotics: a population-based case-control study. Gasse C; Jacobsen J; Pedersen L; Mortensen PB; Nørgaard M; Sørensen HT; Johnsen SP Pharmacotherapy; 2008 Jan; 28(1):27-34. PubMed ID: 18154471 [TBL] [Abstract][Full Text] [Related]
26. Oral hypoglycaemic agents and the development of non-fatal cardiovascular events in patients with type 2 diabetes mellitus. Hung YC; Lin CC; Wang TY; Chang MP; Sung FC; Chen CC Diabetes Metab Res Rev; 2013 Nov; 29(8):673-9. PubMed ID: 23956007 [TBL] [Abstract][Full Text] [Related]
27. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Nunez L; Gudbjörnsdóttir S; Eliasson B Diabetologia; 2009 Jan; 52(1):65-73. PubMed ID: 18985314 [TBL] [Abstract][Full Text] [Related]
28. The R230C variant of the ATP binding cassette protein A1 (ABCA1) gene is associated with a decreased response to glyburide therapy in patients with type 2 diabetes mellitus. Aguilar-Salinas CA; Muñoz-Hernandez LL; Cobos-Bonilla M; Ramírez-Márquez MR; Ordoñez-Sanchez ML; Mehta R; Medina-Santillan R; Tusie-Luna MT Metabolism; 2013 May; 62(5):638-41. PubMed ID: 23273975 [TBL] [Abstract][Full Text] [Related]
29. Gallstones, gallbladder disease, and pancreatitis: cross-sectional and 2-year data from the Swedish Obese Subjects (SOS) and SOS reference studies. Torgerson JS; Lindroos AK; Näslund I; Peltonen M Am J Gastroenterol; 2003 May; 98(5):1032-41. PubMed ID: 12809825 [TBL] [Abstract][Full Text] [Related]
30. Increased relative risk of acute pancreatitis in zolpidem users. Lai SW; Lin CL; Liao KF Psychopharmacology (Berl); 2015 Jun; 232(12):2043-8. PubMed ID: 25491930 [TBL] [Abstract][Full Text] [Related]
31. All-Cause and Cardiovascular Mortality following Treatment with Metformin or Glyburide in Patients with Type 2 Diabetes Mellitus. Raee MR; Nargesi AA; Heidari B; Mansournia MA; Larry M; Rabizadeh S; Zarifkar M; Esteghamati A; Nakhjavani M Arch Iran Med; 2017 Mar; 20(3):141-146. PubMed ID: 28287807 [TBL] [Abstract][Full Text] [Related]
32. The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity. Peeters PJ; Bazelier MT; Leufkens HG; de Vries F; De Bruin ML Diabetes Care; 2015 Mar; 38(3):495-502. PubMed ID: 25552419 [TBL] [Abstract][Full Text] [Related]
33. Long-term safety of pioglitazone versus glyburide in patients with recently diagnosed type 2 diabetes mellitus. Jain R; Osei K; Kupfer S; Perez AT; Zhang J Pharmacotherapy; 2006 Oct; 26(10):1388-95. PubMed ID: 16999648 [TBL] [Abstract][Full Text] [Related]
34. The effect of maternal obesity on pregnancy outcomes of women with gestational diabetes controlled with diet only, glyburide, or insulin. Joy S; Roman A; Istwan N; Rhea D; Desch C; Stanziano G; Saltzman D Am J Perinatol; 2012 Sep; 29(8):643-8. PubMed ID: 22644829 [TBL] [Abstract][Full Text] [Related]
35. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus. Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768 [TBL] [Abstract][Full Text] [Related]
36. Incretin-based pharmacotherapy and risk of adverse pancreatic events in the ethnic Chinese with diabetes mellitus: A population-based study in Taiwan. Tseng CM; Liao WC; Chang CY; Lee CT; Tseng CH; Hsu YC; Lin JT Pancreatology; 2017; 17(1):76-82. PubMed ID: 27743712 [TBL] [Abstract][Full Text] [Related]
37. Use of Simvastatin and Risk of Acute Pancreatitis: A Nationwide Case-Control Study in Taiwan. Lin CM; Liao KF; Lin CL; Lai SW J Clin Pharmacol; 2017 Jul; 57(7):918-923. PubMed ID: 28301063 [TBL] [Abstract][Full Text] [Related]
38. Risk Factors for Hypoglycemia with the Use of Enteral Glyburide in Neurocritical Care Patients. Armahizer MJ; Howard AK; Seung H; Kalasapudi L; Sansur C; Morris NA World Neurosurg; 2021 Mar; 147():e63-e68. PubMed ID: 33253952 [TBL] [Abstract][Full Text] [Related]
39. Amiodarone use and risk of acute pancreatitis: A population-based case-control study. Lai SW; Lin CL; Liao KF; Lin CY Heart Rhythm; 2015 Jan; 12(1):163-6. PubMed ID: 25176392 [TBL] [Abstract][Full Text] [Related]
40. Incidence and precipitants of hospitalization for pancreatitis in people with diabetes: the Fremantle Diabetes Study. Davis TM; Drinkwater J; Davis WA Diabet Med; 2014 Aug; 31(8):913-9. PubMed ID: 24661305 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]